ACM three-lens brief
Evidence-based stock research on ACM. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Outperforming SPY by 19.5pp over 30 days. · RSI at 73 — technically overbought.
- RSI at 73 — technically overbought.
- Outperforming SPY by 19.5pp over 30 days.
- Analyst mean target $83.92 — 19% above current (12 analysts).
- Earnings in 4 days (2026-11-16).
ACM closed at $70.25 (-0.54%) as of 2026-11-12. Market cap: $9.04B. P/E (trailing) 24.7. Price is above the 50-day MA and below the 200-day MA. Positives: outperforming SPY by 19.5pp over 30 days.; analyst mean target $83.92 — 19% above current (12 analysts).. Concerns: rSI at 73 — technically overbought.; earnings in 4 days (2026-11-16).. Last quarter: Revenue $3.59B, net income -$86.71M, free cash flow $379.88M. Watching for: 2026-11-16 earnings release (4 days out).
Why three lenses on ACM, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ACM across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ACM" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ACM brief"></iframe>